Thu, May 19, 2022
Wed, May 18, 2022
Tue, May 17, 2022
Mon, May 16, 2022
Sun, May 15, 2022
Fri, May 13, 2022

Jason Gerberry Upgraded (TEVA) to Hold and Held Target at $9 on, May 17th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -hold-and-held-target-at-9-on-may-17th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Jason Gerberry of B of A Securities, Upgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Hold and Held Target at $9 on, May 17th, 2022.

Jason has made no other calls on TEVA in the last 4 months.



There are 4 other peers that have a rating on TEVA. Out of the 4 peers that are also analyzing TEVA, 2 agree with Jason's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Nathan Rich of "Goldman Sachs" Maintained at Hold with Decreased Target to $9 on, Thursday, May 12th, 2022
  • Jasper Hellweg of "Argus Research" Downgraded from Strong Buy to Hold on, Thursday, January 27th, 2022


These are the ratings of the 2 analyists that currently disagree with Jason


  • David Amsellem of "Piper Sandler" Downgraded from Hold to Sell and Decreased Target to $7 on, Wednesday, May 4th, 2022
  • Balaji Prasad of "Barclays" Upgraded from Hold to Buy and Increased Target to $13 on, Tuesday, April 5th, 2022

Publication Contributing Sources